Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06399471 · ClinicalTrials.gov registry record · NA
Personalizing MPK Prescription
A NA study, sponsored by Georgia Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT06399471 is a NA study that has completed, run by Georgia Institute of Technology. The registered enrollment target is 11 participants.
The verdict
NCT06399471, a NA study, has completed, sponsored by Georgia Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
In current clinical prosthetic practice, there is no evidence based method for selecting a microprocessor knee (MPK) joint for a patient with an above the knee amputation. Of individuals with amputation in veteran and service member populations, approximately 35% present with an above the knee amputation. It is well understood in clinical practice that MPKs provide numerous benefits to patients with amputations above the knee including improved gait, safety, comfort, confidence, reduced falls, balance, patient satisfaction and reduced energy expenditure, greater ease in negotiating varying terrains, improvements in multi-tasking and cost effectiveness. Studies that have investigated commercially available MPKs tend to lump all of them together within a single group rather than teasing out individual differences between each knee. Therefore, clinicians are left to rely on their own intuition and past experiences with an MPK when selecting for a patient with an above the knee amputation rather than making their decision based on evidence collected from the specific patient. This may mean that some individuals with an above the knee amputation may not be receiving the best component for them which may delay or inhibit their rehabilitation potential following their amputation.
Interventions
- DEVICE Microprocessor prosthetic knee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2023-10-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06399471
The ClinicalTrials.gov registry entry for NCT06399471 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgia Institute of Technology, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Microprocessor prosthetic knee is the first listed.
NCT06399471 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06399471 about?
NCT06399471 is a clinical study titled "Personalizing MPK Prescription". In current clinical prosthetic practice, there is no evidence based method for selecting a microprocessor knee (MPK) joint for a patient with an above the knee amputation. Of individuals with amputation in veteran and service member populations, approximately 35% present with an above the knee amput...
What is the current status of trial NCT06399471?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2021-10-25. Estimated completion is 2023-10-02.
What interventions are being tested in trial NCT06399471?
The interventions under investigation include: Microprocessor prosthetic knee (DEVICE).
Who is sponsoring clinical trial NCT06399471?
This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.